brimonidine tartrate has been researched along with enkephalin, methionine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzgerald, RD; Harris, GC | 1 |
| Christie, MJ; Miyake, M; North, RA | 1 |
| Bobker, DH; Shen, KZ; Surprenant, A; Williams, JT | 1 |
| Chieng, B; Christie, MJ; Connor, M | 1 |
| Ingram, S; McCleskey, EW; Wilding, TJ; Williams, JT | 1 |
| Dang, VC; Williams, JT | 1 |
| Beckstead, MJ; Paladini, CA; Weinshenker, D | 1 |
| Arttamangkul, S; Birdsong, WT; Virk, MS; Williams, JT | 1 |
8 other study(ies) available for brimonidine tartrate and enkephalin, methionine
| Article | Year |
|---|---|
Effects of centrally administered anxiolytic agents on classically conditioned bradycardia.
Topics: Animals; Anti-Anxiety Agents; Arousal; Brain; Brain Mapping; Brimonidine Tartrate; Clonidine; Conditioning, Classical; Corticotropin-Releasing Hormone; Enkephalin, Methionine; Heart Rate; Male; Peptide Fragments; Quinoxalines; Rats; Reflex, Startle | 1991 |
Single potassium channels opened by opioids in rat locus ceruleus neurons.
Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Brimonidine Tartrate; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Electric Conductivity; Endorphins; Enkephalin, Methionine; Locus Coeruleus; Membrane Potentials; Naloxone; Neurons; Potassium Channels; Quinoxalines; Rats; Receptors, Adrenergic, alpha; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Opioid, mu; Receptors, Somatostatin; Somatostatin | 1989 |
DTG and (+)-3-PPP inhibit a ligand-activated hyperpolarization in mammalian neurons.
Topics: Animals; Brimonidine Tartrate; Dopamine Agents; Enkephalin, Methionine; Guanidines; Haloperidol; Male; Membrane Potentials; Neurons; Norepinephrine; Piperidines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Serotonin | 1989 |
The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Topics: Animals; Brimonidine Tartrate; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Methionine; Enkephalins; In Vitro Techniques; Kinetics; Locus Coeruleus; Male; Naloxone; Narcotics; Neurons; Nociceptin; Opioid Peptides; Peptide Fragments; Peptides; Potassium; Potassium Channels; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Somatostatin | 1996 |
Efficacy and kinetics of opioid action on acutely dissociated neurons.
Topics: Animals; Brimonidine Tartrate; Calcium Channels; Clonidine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Methionine; Enkephalins; Etorphine; Locus Coeruleus; Morphine; Narcotics; Potassium Channels; Quinoxalines | 1997 |
Chronic morphine treatment reduces recovery from opioid desensitization.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cocaine; Drug Tolerance; Enkephalin, Methionine; Leucine; Locus Coeruleus; Male; Monensin; Morphine; Morphine Dependence; Morphine Derivatives; Norepinephrine; Phosphorylation; Prazosin; Protein Kinase C; Protein Processing, Post-Translational; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Staurosporine; Thiorphan; Yohimbine | 2004 |
Electrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouse.
Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Autoreceptors; Brimonidine Tartrate; Dopamine beta-Hydroxylase; Electric Stimulation; Enkephalin, Methionine; Locus Coeruleus; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Norepinephrine; Organ Culture Techniques; Patch-Clamp Techniques; Quinoxalines; Receptors, Adrenergic, alpha-2; Substantia Nigra; Synaptic Transmission | 2007 |
Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Biophysics; Brain; Brimonidine Tartrate; Buprenorphine; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Methionine; In Vitro Techniques; Male; Membrane Potentials; Mice; Mice, Transgenic; Naltrexone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Yohimbine | 2009 |